A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the potential PK interaction between ABT-335,
atorvastatin 80 mg and ezetimibe 10 mg when administered concurrently.